Financials
- Market Capitalization 3.9607 B
- Employee 100
- Founded 2019
- CEO N/A
- Website www.newamsterdampharma.com
- Headquarter Netherlands
- FIGI N/A
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-13.43
Rapporto prezzo/fatturato
121.57
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3331 | OABI OmniAb, Inc. - Common Stock | 2.15 USD | +1.90% | -7.33% | -6.93% | +3.86% | 311.69 M USD | ||
| 6552 | RVMDW Revolution Medicines, Inc. - Warrant | 9.1399 USD | +1.89% | -6.59% | +53.61% | +3555.96% | 39.32 B USD | ||
| 6876 | DRTSW Alpha Tau Medical Ltd. - Warrant | 3.4000 USD | +4.43% | +3.34% | +61.90% | +1114.29% | 1.09 B USD | ||
| 6958 | XOMAO XOMA Royalty Corporation - Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | 25.00 USD | 0.00% | +0.16% | -1.54% | -1.22% | 503.77 M USD |